Antiarrhythmic and cardiohemodynamic effects of a novel Ca2+ channel blocker, AH-1058, assessed in canine arrhythmia models
- 8 June 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 398 (1) , 107-112
- https://doi.org/10.1016/s0014-2999(00)00293-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Acute Antiarrhythmic Effects of Intravenously Administered Amiodarone on Canine Ventricular ArrhythmiaJournal of Cardiovascular Pharmacology, 1995
- Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: Which electrophysiological characteristics of drugs are related to their effectiveness?Cardiovascular Drugs and Therapy, 1991
- Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.Japanese Heart Journal, 1989
- Antiarrhythmic Plasma Concentrations of Pirmenol on Canine Ventricular ArrhythmiasThe Japanese Journal of Pharmacology, 1988
- Antiarrhythmic Plasma Concentrations of Cibenzoline on Canine Ventricular ArrhythmiasJournal of Cardiovascular Pharmacology, 1987
- Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: A comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165Heart and Vessels, 1985
- Antiarrhythmic Effects of Coronary Vasodilators on Canine Ventricular Arrhythmia ModelsThe Japanese Journal of Pharmacology, 1984
- Delayed afterdepolarizations and triggered activity induced in feline Purkinje fibers by alpha-adrenergic stimulation in the presence of elevated calcium levels.Circulation, 1984
- Antiarrhythmic Plasma Concentrations of Mexiletine on Canine Ventricular ArrhythmiasJournal of Cardiovascular Pharmacology, 1984
- Triggered ventricular rhythms in 1-day-old myocardial infarction in the dog.Circulation Research, 1983